Literature DB >> 14695406

A new insight into the formation of osteolytic lesions in multiple myeloma.

Donald A Glass1, Millan S Patel, Gerard Karsenty.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14695406     DOI： 10.1056/NEJMp038176

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  7 in total

Review 1.  Diseases of Wnt signaling.

Authors:  Mark L Johnson; Nalini Rajamannan
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 6.514

Review 2.  Tumors of the osseous spine.

Authors:  Narayan Sundaresan; Stephano Boriani; Allen Rothman; Robert Holtzman
Journal:  J Neurooncol       Date:  2004 Aug-Sep       Impact factor: 4.130

3.  Medication-related osteonecrosis of the jaw (MRONJ) and eNOS Polymorphisms in multiple myeloma patients: a single center experience.

Authors:  Betul Taş Ozyurtseven; Istemi Serin; Ayse Feyda Nursal; Sacide Pehlivan; Mustafa Pehlivan
Journal:  BMC Oral Health       Date:  2021-05-18       Impact factor: 2.757

4.  Myeloma cells inhibit osteogenic differentiation of mesenchymal stem cells and kill osteoblasts via TRAIL-induced apoptosis.

Authors:  Jinxiang Fu; Panjun Wang; Xiaohui Zhang; Suguang Ju; Jie Li; Binzhou Li; Sun Yu; Jianhua Zhang; Xueguang Zhang
Journal:  Arch Med Sci       Date:  2010-09-07       Impact factor: 3.318

5.  Hypophosphatemic osteomalacia: an unusual clinical presentation of multiple myeloma.

Authors:  M Reyskens; K Sleurs; L Verresen; M Janssen; J van den Bergh; J van den Berg; P Geusens
Journal:  Osteoporos Int       Date:  2015-04-24       Impact factor: 4.507

6.  Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway.

Authors:  Ikiru Atsuta; Shiyu Liu; Yasuo Miura; Kentaro Akiyama; Chider Chen; Ying An; Songtao Shi; Fa-Ming Chen
Journal:  Stem Cell Res Ther       Date:  2013       Impact factor: 6.832

7.  Multiple myeloma and paget disease with abnormal skull lesions and intracranial hypertension.

Authors:  T Caravita; A Siniscalchi; E Montinaro; R Bove; M Zaccagnini; D De Pascalis; A Morocutti; L Brusa; F Arciprete; Ml Cupini; A Perrotti; E Palma; S Fratoni; R De Simone; C Iani; P de Fabritiis
Journal:  Mediterr J Hematol Infect Dis       Date:  2012-11-05       Impact factor: 2.576
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.